Jiménez, E.; Vázquez, A.; González, S.; Sacedón, R.; Fernández-Sevilla, L.M.; Varas, A.; Subiza, J.L.; Valencia, J.; Vicente, Á.
Mucosal Bacterial Immunotherapy Attenuates the Development of Experimental Colitis by Reducing Inflammation Through the Regulation of Myeloid Cells. Int. J. Mol. Sci. 2024, 25, 13629.
https://doi.org/10.3390/ijms252413629
AMA Style
Jiménez E, Vázquez A, González S, Sacedón R, Fernández-Sevilla LM, Varas A, Subiza JL, Valencia J, Vicente Á.
Mucosal Bacterial Immunotherapy Attenuates the Development of Experimental Colitis by Reducing Inflammation Through the Regulation of Myeloid Cells. International Journal of Molecular Sciences. 2024; 25(24):13629.
https://doi.org/10.3390/ijms252413629
Chicago/Turabian Style
Jiménez, Eva, Alberto Vázquez, Sara González, Rosa Sacedón, Lidia M. Fernández-Sevilla, Alberto Varas, Jose L. Subiza, Jaris Valencia, and Ángeles Vicente.
2024. "Mucosal Bacterial Immunotherapy Attenuates the Development of Experimental Colitis by Reducing Inflammation Through the Regulation of Myeloid Cells" International Journal of Molecular Sciences 25, no. 24: 13629.
https://doi.org/10.3390/ijms252413629
APA Style
Jiménez, E., Vázquez, A., González, S., Sacedón, R., Fernández-Sevilla, L. M., Varas, A., Subiza, J. L., Valencia, J., & Vicente, Á.
(2024). Mucosal Bacterial Immunotherapy Attenuates the Development of Experimental Colitis by Reducing Inflammation Through the Regulation of Myeloid Cells. International Journal of Molecular Sciences, 25(24), 13629.
https://doi.org/10.3390/ijms252413629